Madison, New Jersey, United States
Over two decades creating value from health care data, analytics and enabling technologies.
I have deep domain in creating value from health care data at scale, associated analytics and enabling technologies across Life Science/Biotech, payers, patients, providers, medical societies and government agencies. Long experience with start-ups as well as VC/PE firms. Serve on multiple Boards. Execullence is a growth strategy and execution firm founded under the premise that revenue growth by design, not by default, is the key to both profitability and optimal valuation. Our managing partners and executive consultants each have over 25 years of C-suite operating experience, spanning venture backed startups, growth equity, turnarounds, IPOs and large multinationals. The Execullence Roadmap to Strategic Growth covers all phases from Readiness to Execution to Scale. We are often called on to help bring strategic planning to life, through actionable analytics, vastly improved targeting and positioning, sales process management and development of programs that energize go-to-market efforts when other methods are either stalled or exhausted.
CancerLinQ™is a cutting-edge health information technology (HIT) platform that will revolutionize how we care for people with cancer. By enabling us to learn from each of the millions of individual patients living with cancer nationwide, CancerLinQ will improve the quality and value of cancer care for all. CancerLinQ is a program from the American Society of Clinical Oncology Institute for Quality. Lead responsibility for developing and implementing numerous initiatives that enhance the value of the CancerLinQ platform for providers, patients and other stakeholders
An independent consultant with deep expertise in health care data, analytics and enabling technologies, working directly with companies ranging from start ups to large, mature organizations and medical societies. My activities focus on identifying opportunities for growth, often playing a hands on operational role in developing and executing them. I also serve as an advisor to several VC/PE firms. On several occasions I've served short term line assignments, both as a line manager or consultant/member of the management team to lead development efforts or in executive roles. Notable examples include CEO of Cognia (2007-8), General Manager, Life Sciences Symphony Metreo (2010) or Managing Partner of Empirical,
COO and Board Member of cutting edge start up in proteomic information solutions. Doubled revenue and led successful exit returning over 200% to investors.
Developed and led to market leadership several information products, notably IMS's flagship brand Xponent, in U.S., Europe and select countries in Asia, producing revenue exceeding $500M/year.